Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Arbor Pharmaceuticals, Inc. | 24338-106 | ORAL | 250 mg in 1 1 | 12/4/2018 | |
| PD-Rx Pharmaceuticals, Inc. | 55289-112 | ORAL | 250 mg in 1 1 | 9/22/2023 | |
| Blenheim Pharmacal, Inc. | 10544-594 | ORAL | 250 mg in 1 1 | 3/30/2015 | |
| Blenheim Pharmacal, Inc. | 10544-595 | ORAL | 500 mg in 1 1 | 3/30/2015 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| EROTAB 250 TAB 250MG | N/A | N/A | N/A | 2/18/1992 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| ERYTHROCIN LIQ 250 | ABBOTT LABORATORIES, LIMITED | 00273023 | Liquid - Oral | 50 MG / ML | 12/31/1973 |
| ERYTHROMYCINE 250 TAB | PRO DOC LIMITEE | 00563854 | Tablet - Oral | 250 MG | 12/31/1982 |
| ERYTHRO-500 TAB 500MG USP | PRO DOC LIMITEE | 00704393 | Tablet - Oral | 500 MG | 12/31/1987 |
| ERYTHROCIN LIQUID 125 | ABBOTT LABORATORIES, LIMITED | 00000302 | Liquid - Oral | 25 MG / ML | 12/31/1970 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.